Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patients.

doi:10.1016/s0165-1781(96)02999-x

Back to search

Article

Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patients.

Psychiatry research - 24 Mar 1997

Lane H Y, Hu O Y, Jann M W, Deng H C, Lin H N, Chang W H

Abstract excerpt

This study examined the relationship between the metabolic ratios of dextromethorphan/dextrorphan, haloperidol disposition, and the incidence of extrapyramidal side effects in schizophrenic patients. Eighteen schizophrenic patients were phenotyped with a test dose of dextromethorphan prior to the...

Topics

Adult
Asian People
Basal Ganglia Diseases
Dextromethorphan
Female
Haloperidol
Humans
Male
Phenotype
Schizophrenia
White People

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.